Writing

Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.

📚 Books

Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.

Both books are published globally on Amazon (Kindle & Paperback editions available).

🟦 The Mind Game of Trading

Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari

Overview

Trading success is rarely limited by strategy. It is limited by psychology.

In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.

The book focuses on:

• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks

This is not a theory book — it is a practical discipline manual for traders at all levels.

🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2

🟦 The Stock Market Starter Kit

Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari

Overview

Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.

It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.

It covers:

• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans

Clear. Structured. Actionable.

🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV



  • TCS Q2 FY26 Results: Revenue Up, $6B Data Center Plan Explained

    Imagine running a business the size of TCS, employing over half a million people across the globe. Every quarter, investors, analysts, and employees watch closely—not just for profits, but for signals of growth, transformation, and resilience. TCS’s Q2 FY26 results have just dropped, and they’re packed with insights that matter to anyone tracking Indian IT…


  • “Tata Sons Listing Demand — Inside SP vs Trusts Clash”

    “SP Group pushes Tata Sons public listing amid boardroom rift and RBI’s Sep 2025 deadline. Unpack governance clash, minority rights & possible outcomes.” Have you ever seen someone press you from one side while pushing you from the other — and you realize you’re stuck in the tug of dual forces? India’s corporate world is…


  • “TCS Layoffs 20,000, Hires 5,000 in UK: Strategic Pivot or Mixed Message?”

    “TCS cuts nearly 20,000 jobs globally while pledging 5,000 UK hires — a bold strategy pivot. Unpack rationale, risks, and lessons for India’s tech era.” What if your employer — a tech giant you’ve trusted — suddenly announced mass job cuts, and the next week proclaimed it would hire thousands in another country? That’s exactly…


  • “LG Electronics IPO: Hype, Risk & How Much You Could Gain”

    “Get a full, human-level breakdown of the LG Electronics IPO: allotment steps, subscription records, risks, listing outlook & post-IPO playbook.” Think about a time when your friends or colleagues collectively rushed to buy a limited-edition gadget right on Day 1 — and the stock for that gadget shot up within hours. That’s exactly the kind…


  • “India: The New Engine of Global Economic Growth”

    India emerges as a global economic powerhouse, with the IMF highlighting its pivotal role amid shifting global growth dynamics. In a world where economic powerhouses like China are experiencing a slowdown, India is stepping up as the new engine of global growth. This shift is not just a statistical anomaly but a testament to India’s…


  • How the U.S. Shelved Tariffs on Generic Drugs — A Lifeline for India’s Pharma

    White House shelves tariffs on generic drugs, easing pressure on U.S. patients and Indian pharma exports—insight into impact, risks, and strategy. Imagine walking into a pharmacy tomorrow, only to find your essential medications have suddenly skyrocketed in price. For millions of Americans and healthcare systems worldwide, the threat of tariffs on pharmaceutical imports is more…


Scroll to Top